Please try another search
Cello Health plc, together with its subsidiaries, offers marketing services in the United Kingdom, the rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment offers market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is based in London, the United Kingdom. As of August 11, 2020, Cello Health plc operates as a subsidiary of Value Demonstration UK Holdings Limited.
Name | Age | Since | Title |
---|---|---|---|
Mark Scott | 59 | 2004 | CEO & Executive Director |
Julia Anne Ralston | 67 | 2018 | Executive Director |
Joanna Susan LeCouilliard | 61 | 2018 | Independent Non-Executive Director |
Stephen Highley | 64 | - | Group COO & Director |
Christopher Ian Montague Jones | 29 | 2016 | Independent Non-Executive Chairman |
Mark Bentley | 54 | 2005 | Group Finance Director & Executive Director |
Stephen Pidgeon | - | - | Chairman of Tangible Response |
Clifford Peter Tompsett | 67 | 2018 | Senior Independent Non-Executive Director |
Michele Luzi | 68 | 2018 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review